4.8 Article

Identification and Tracking of Alloreactive T Cell Clones in Rhesus Macaques Through the RM-scTCR-Seq Platform

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.804932

Keywords

TCR sequencing; single cell sequencing; alloreactive T cells; Rhesus Macaque (Macaca mulatta); GVHD

Categories

Funding

  1. Helen Gurley Brown Foundation
  2. National Cancer Center
  3. NIH [U19 Al1051731, P01 HL158504, 5T32HL007574-40, 5U24AI118672, 2R01HL095791]
  4. ASTCT New Investigator Award
  5. CIBMTR/Be The Match Foundation
  6. Searle Scholars Program
  7. Beckman Young Investigator Program
  8. Sloan Fellowship in Chemistry
  9. Leukemia and Lymphoma Society TRP grant
  10. [R01 HL095791]

Ask authors/readers for more resources

The new RM-scTCR-Seq pipeline enables the amplification, reconstruction, and pairing of RM-specific single-cell TCRs with their transcriptional profiles for the first time. This method allows for the identification and tracking of alloreactive clonotypes detected in RM, as well as exploration of their GVHD-driven cytotoxic T cell characteristics in target organs. This novel platform fundamentally advances the utility of RM in studying protective and pathogenic T cell responses.
T cell receptor (TCR) clonotype tracking is a powerful tool for interrogating T cell mediated immune processes. New methods to pair a single cell's transcriptional program with its TCR identity allow monitoring of T cell clonotype-specific transcriptional dynamics. While these technologies have been available for human and mouse T cells studies, they have not been developed for Rhesus Macaques (RM), a critical translational organism for autoimmune diseases, vaccine development and transplantation. We describe a new pipeline, 'RM-scTCR-Seq', which, for the first time, enables RM specific single cell TCR amplification, reconstruction and pairing of RM TCR's with their transcriptional profiles. We apply this method to a RM model of GVHD, and identify and track in vitro detected alloreactive clonotypes in GVHD target organs and explore their GVHD driven cytotoxic T cell signature. This novel, state-of-the-art platform fundamentally advances the utility of RM to study protective and pathogenic T cell responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available